GCT Semiconductor Secures New $20M Convertible Note Facility Amidst Deepening Losses and Going Concern Warning
GCTS sits 22% above its 52-week low of $0.9.
Summary
GCT Semiconductor reported a significant deterioration in 2025 financial results, including a 69% revenue drop and a widened net loss, prompting a going concern warning, while simultaneously announcing a new $20 million dilutive convertible note facility and recent ATM share sales to address critical liquidity needs.
Key Events · Financing and Capital Events · GCTS
-
Auditors Issue Going Concern Warning
The independent registered accounting firm expressed 'substantial doubt' about GCT Semiconductor's ability to continue as a going concern, citing recurring operating losses and negative cash flows.
-
Severe Financial Deterioration in 2025
Net revenues plummeted 69% to $2.9 million in 2025 from $9.1 million in 2024. The company reported a negative gross profit of $(1.8) million and a net loss of $(43.4) million, a 250% increase from the prior year.
-
New $20M Convertible Note Facility Announced
On March 25, 2026, GCT Semiconductor entered into a convertible promissory note purchase agreement with Obsidian Global GP LLC for up to $20 million, with notes convertible at 95% of the 3-day VWAP and issued at a 3.5% original issue discount.
-
Significant Post-Year-End Equity Sales
In January and February 2026, the company sold approximately 9.9 million shares for $12.6 million under its At-The-Market (ATM) agreement, with $38.7 million remaining available for future issuance.
Analysis · GCTS · Manufacturing
GCT Semiconductor's 2025 annual report reveals a company in severe financial distress, marked by a significant decline in revenue, negative gross margins, and a substantial increase in net loss, leading auditors to express 'substantial doubt' about its ability to continue as a going concern. The company is actively pursuing highly dilutive financing strategies to address its liquidity crisis. The newly disclosed $20 million convertible note facility with Obsidian Global GP LLC, entered into on the same day as this filing, offers capital at a 5% discount to the market price, highlighting the urgent need for funds. This, coupled with recent ATM sales of $12.6 million and other dilutive equity issuances, indicates a challenging path forward for existing shareholders. The reliance on related-party debt and the incurrence of penalties on overdue loans further underscore the precarious financial position.
At the time of this filing, GCTS was trading at $1.10 on NYSE in the Manufacturing sector, with a market capitalization of approximately $94.2M. The 52-week trading range was $0.90 to $2.47. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.